Moreover, although the ASGPR enriched HLCs no longer caused teratoma formation, well-differentiated adenocarcinomas were found in the peritoneum of the rats, indicating that tumor formation remains a risk when using EB-derived HLCs and that a more directed and better controlled differentiation of PSCs towards hepatocytes is needed to prevent tumor formation. Here, ASGR1 is linked to neoplasm.